下载PDF
{"title":"Generation of Human Induced Pluripotent Stem Cells Using a Defined, Feeder-Free Reprogramming System","authors":"Seonmi Park, Gustavo Mostoslavsky","doi":"10.1002/cpsc.48","DOIUrl":null,"url":null,"abstract":"<p>Human induced pluripotent stem cells (hiPSCs) offer great opportunities for the study of human development and disease modeling and have enormous potential for use in future clinical cell-based therapies. However, most current systems to create hiPSCs often expose the cells to animal feeder layers or xenogeneic reagents; this raises safety concerns about using hiPSC-derived cells for therapeutic purposes. Here, we describe protocols to generate hiPSCs without exposing the cells to xenogeneic materials that uses a defined, feeder-free reprogramming system. With this method, we were able to successfully reprogram not only patient-derived peripheral blood mononuclear cells but also amniocytes from the amniotic fluid of stillborn fetuses using two independent reprogramming platforms. Importantly, hiPSCs generated in this fashion expressed pluripotent markers and had normal karyotypes. The protocols allowed us to generate and culture hiPSCs under Good Manufacturing Practice–like conditions, a necessary step for the future clinical application of these cells. © 2018 by John Wiley & Sons, Inc.</p>","PeriodicalId":53703,"journal":{"name":"Current Protocols in Stem Cell Biology","volume":"45 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/cpsc.48","citationCount":"13","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Protocols in Stem Cell Biology","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cpsc.48","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 13
引用
批量引用
Abstract
Human induced pluripotent stem cells (hiPSCs) offer great opportunities for the study of human development and disease modeling and have enormous potential for use in future clinical cell-based therapies. However, most current systems to create hiPSCs often expose the cells to animal feeder layers or xenogeneic reagents; this raises safety concerns about using hiPSC-derived cells for therapeutic purposes. Here, we describe protocols to generate hiPSCs without exposing the cells to xenogeneic materials that uses a defined, feeder-free reprogramming system. With this method, we were able to successfully reprogram not only patient-derived peripheral blood mononuclear cells but also amniocytes from the amniotic fluid of stillborn fetuses using two independent reprogramming platforms. Importantly, hiPSCs generated in this fashion expressed pluripotent markers and had normal karyotypes. The protocols allowed us to generate and culture hiPSCs under Good Manufacturing Practice–like conditions, a necessary step for the future clinical application of these cells. © 2018 by John Wiley & Sons, Inc.
使用一种明确的、无馈源的重编程系统生成人类诱导多能干细胞
人类诱导多能干细胞(hiPSCs)为人类发育和疾病建模研究提供了巨大的机会,在未来的临床细胞治疗中具有巨大的潜力。然而,目前大多数制造hipsc的系统通常将细胞暴露于动物饲养层或异种试剂中;这引起了使用hipsc衍生细胞用于治疗目的的安全性担忧。在这里,我们描述了在不将细胞暴露于异种材料的情况下生成hipsc的方案,该方案使用定义的,无馈线的重编程系统。通过这种方法,我们不仅能够成功地对患者外周血单核细胞进行重编程,还能够使用两个独立的重编程平台对死胎羊水中的羊膜细胞进行重编程。重要的是,以这种方式产生的hiPSCs表达多能性标记物,并且具有正常的核型。该方案允许我们在类似良好生产规范的条件下生成和培养hipsc,这是这些细胞未来临床应用的必要步骤。©2018 by John Wiley &儿子,Inc。
本文章由计算机程序翻译,如有差异,请以英文原文为准。